Park Medi World Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹460Cr
- +29.9% YoY
- +12.2% QoQ
- Net profit
- ₹77Cr
- +48.1% YoY
- +45.3% QoQ
- Margin
- 28%
- +3 pp YoY
- +4 pp QoQ
Guidance rank: #14 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela. The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over 10,000 by FY’33, potentially doubling capacity.
From Park Medi World's Q4 FY26 earnings-call transcript · updated 24 Aug 2026.
Revenue & Sales Performance
- Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela.
- Capex guidance: INR55 crores planned for the current year and approximately INR250 crores in FY28 for adding 1,000 beds.
- Long-term vision (FY28 to FY33): Plans to double bed capacity from 5,460 to over 10,000 beds.
- Expansion focus on Tier-2 and Tier-3 cities due to growing demand for affordable, high-quality healthcare, reducing patient outflow to metros.
- Continued increase in government insurance payor mix expected to stabilize around 70%.
2 more points from Park Medi World's call on revenue
Create a free account to keep reading this call
Profitability & Margins
The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over…
Locked: what Park Medi World said on margins
Also locked on this page: fundraising
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
- Park Medi World is undertaking a significant bed expansion with a capex of about INR 34 lakhs per bed, aiming to increase capacity to 5,460 beds by FY’28 and potentially doubling to over 10,000 beds by FY’33.
- Current capex underway includes:
- Panchkula: 350 beds with INR 125 crores invested.
- Delhi Narela: 200 beds with total planned capex INR 80 crores (INR 55 crores spent).
- Kanpur: Additional INR 30 crores planned.
- Capex planned for FY’27 is about INR 55 crores; for FY’28, approximately INR 250 crores.
2 more points from Park Medi World's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
The company currently has sufficient funds, including close to INR314 crores in fixed deposits and about…
Locked: what Park Medi World said on fundraising
Also locked on this page: margins
Free account, 30 seconds. No card needed.
Order Book & Pipeline
- The company currently has approximately 1,500 beds under execution.
- These new capacity additions are expected to be operational by March 2028.
- This expansion will increase total bed capacity to 5,460 by that time.
- Total planned capex for the next two years is around INR 500 crores.
- Recent investments include Panchkula Greenfield construction, and acquisitions/commissioning of Bathinda, Agra, and Narela hospitals.
2 more points from Park Medi World's call on order book
Create a free account to keep reading this call
Park Medi World — Quarterly revenue & net profit
Park Medi World Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 460 | 354 | +29.9% | 410 | +12.2% |
| Operating profit (EBITDA) | 127 | 88 | +44.3% | 99 | +28.3% |
| Operating margin | 28% | 25% | +3 pp | 24% | +4 pp |
| Profit before tax | 103 | 66 | +56.1% | 78 | +32.1% |
| Net profit (PAT) | 77 | 52 | +48.1% | 53 | +45.3% |
| EPS (₹) | 1.64 | 1.17 | +40.2% | 1.17 | +40.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹476 Cr, net profit ₹89 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Park Medi World's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Park Medi World and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Park Medi World Q4 FY26 results?
Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela. The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over 10,000 by FY’33, potentially doubling capacity.
What is Park Medi World share price analysis?
Park Medi World currently shows a neutral. The stock trades at a P/E of 42.7 with a market cap of ₹11,859 Cr. Investors should review the full earnings analysis for detailed insights.
Is Park Medi World planning capital expenditure?
Park Medi World is undertaking a significant bed expansion with a capex of about INR 34 lakhs per bed, aiming to increase capacity to 5,460 beds by FY’28 and potentially doubling to over 10,000 beds by FY’33.
Keep Park Medi World on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.